Elite Pharmaceuticals Inc (ELTP)

[mrwrn2010]

Maybe. That’s an interesting thought.

Elite’s company blurb lately in the PRs is “a specialty pharmaceutical company engaged in the development, manufacture, and distribution of niche generic products.” I guess that can apply to a tiny drug market of 1-2 competitors or something like Adderrall, Vyvanse, etc.

Gotta consider too that these products take years(?) to go from formulation development to initial trials to human trials to filing to approval, right? Market size can always change in the interim and the number of competitors is definitely in flux. If the idea for this dopamine agonist was several years old, we were bringing in fewer revenues then. Maybe it was a “let’s keep the lights on, go for the easier singles and doubles” before we tackle the home run-type products? Just speculating.